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CHRONIC KIDNEY DISEASE DEFINITION
An alternative classification system for chronic kidney
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We have several comments on Moynihan and colleagues’
excellent article about the overdiagnosis of chronic kidney
disease (CKD).1
Firstly, two large cohort studies with long follow-up have shown
that the chance of developing adverse outcomes (mortality or
need for renal replacement therapy) is much lower in older age
groups.2 3 This finding was confirmed in a large meta-analysis
of the CKD consortium.4
Secondly, the current classification of CKD doesn’t take into
account the evolution of estimated glomerular filtration rate
over time, although it has been shown in several studies,5
including in the oldest old,6 that a rapid decline in this measure
is a good predictor of adverse outcomes.
In 2012 the Belgian guideline for general practitioners on CKD
incorporated these factors (age and rapid decline in estimated
glomerular filtration rate over time) into an alternative CKD
classification. This alternative classification (box) distinguishes
two groups of CKD patients: high risk patients who should be
in a shared care programme and those with intermediate risk
who should be referred for diagnostic investigations.
Use of this alternative classification avoids patients
unnecessarily being labelled as having a chronic disease and
reduces the prevalence of people with “real CKD” from 14%
to about 2% of the population.
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Proposed classification criteria for chronic kidney disease
High risk patients
Patients with eGFR chronically <30 ml/min/1.73m2
Patients with eGFR 30-45 ml/min/1.73m2 and ACR >300 mg/g or PCR >1000 mg/g
Intermediate risk patients
Patients <75 years with eGFR 30-45 ml/min/1.73m2 and ACR of 30-300 mg/g
Patients with eGFR 30-45 ml/min/1.73m2 and a decrease in eGFR of >10 ml/min/1.73m2 in the past five years
Patients with eGFR >45 ml/min and ACR >300 mg/g or PCR >1000 mg/g
ACR=albumin to creatinine ratio; eGFR=estimated glomerular filtration rate; PCR=protein to creatinine ratio.
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